These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4602480)

  • 1. [Clinical study of a new anti-arrhythmic drug (naphyloxy 1)-4 hydroxy-3 butyramidoxime hydiochloride].
    Tricot R; Valere PE; Castillo-Fenoy A
    Therapie; 1973; 28(4):721-34. PubMed ID: 4602480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological study of (naphtyloxy-1)4-hydroxy-3 butyramidoxime chlorhydrate or LL 1530. Anti-arrhythmic action].
    Duteil J; Nadaud J; Henry M; Assous E; Gombert R
    Therapie; 1973; 28(4):703-20. PubMed ID: 4793689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of a new anti-arrhythmia agent: nadoxolol].
    Warembourg H; Ducloux G
    Lille Med; 1976 Apr; 21(4 Suppl 2):386-8. PubMed ID: 957857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-arrhythmic activity of bunaphtin].
    Franchini G; Storelli A; Pierfelice O; Latorre A; Fiandanese F; Rizzon P
    Boll Soc Ital Cardiol; 1974; 19(5):427-33. PubMed ID: 4619020
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polycentric clinical experimentation with a new anti-arrhythmia agent: bunaftide].
    Botti G
    Boll Soc Ital Cardiol; 1972; 17(11):1089-104. PubMed ID: 4620064
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder].
    Smetnev AS; Shugushev KhKh; Rozenshtraukh LV; Shevchenko NM
    Ter Arkh; 1983; 55(1):92-5. PubMed ID: 6340241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
    Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
    Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bunaftine in the treatment of arrhythmias].
    Vegis D
    Cardiol Prat; 1975; 26(1):29-36. PubMed ID: 769979
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of Bradyl 250 in the early phase of myocardial infarct and in the danger syndrome].
    Pauchant MM; Giard A; Decalf A; Decalf Y; Delmon A; Goethals S; Waucampt JJ
    Lille Med; 1976 Sep; 21(7 Suppl 3):595-601. PubMed ID: 792604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Initial experiences in the clinical use of a new anti-arrhythmia agent: bunaftide].
    Lotto A; Lomanto B
    Boll Soc Ital Cardiol; 1972; 17(9):701-4. PubMed ID: 4619966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-arrhythmia treatment (clinical problems, classification of anti-arrhythmia drugs and personal experience].
    Walczak F
    Kardiol Pol; 1992; 36(2):97-104. PubMed ID: 1583833
    [No Abstract]   [Full Text] [Related]  

  • 13. [Observations on the anti-arrhythmic effects of propafenone].
    Ku FS
    Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental study of the anti-arrhythmic action of a new beta-adrenergic blocking agent: hydrobutamine].
    Botti G; Visioli O; Ambanelli U; Barbaresi F; Lazzari G; Dallavalle L
    Folia Cardiol; 1965; 24(5):243-7. PubMed ID: 5898886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Trusz-Gluza M
    Kardiol Pol; 1991; 34(1):41-8. PubMed ID: 2051713
    [No Abstract]   [Full Text] [Related]  

  • 17. [New method for direct study of antiarrhythmic drugs in man. Electrophysiological effects and criteria for interpretation].
    Domenichelli B; Manzoli U; Schiavoni G; Feraco E
    Minerva Cardioangiol; 1974 Feb; 22(2):71-89. PubMed ID: 4820118
    [No Abstract]   [Full Text] [Related]  

  • 18. [A clinical study of bonnecor in the treatment of heart rhythm disorders in patients with ischemic heart disease].
    Gorshkov VA; Solodukhina IS; Kesarev GV; Kurakina TI; Solov'eva FV
    Sov Med; 1991; (7):45-7. PubMed ID: 1948344
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.